NCT03812835View on ClinicalTrials.gov

A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

August 23, 2021

Primary Completion Date

August 23, 2023

Study Completion Date

August 23, 2023

Conditions
Thrombosis, Deep VeinPulmonary Embolism
Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03812835 - A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment | Biotech Hunter | Biotech Hunter